Log in

NYSE:MMS - MAXIMUS Stock Price, Forecast & News

$69.49
-1.09 (-1.54 %)
(As of 02/25/2020 01:39 AM ET)
Today's Range
$68.72
Now: $69.49
$69.97
50-Day Range
$69.49
MA: $73.74
$75.86
52-Week Range
$68.42
Now: $69.49
$82.02
Volume384,500 shs
Average Volume317,981 shs
Market Capitalization$4.44 billion
P/E Ratio18.43
Dividend Yield1.59%
Beta0.82
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
CUSIP57793310
Phone703-251-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.89 billion
Cash Flow$5.04 per share
Book Value$19.56 per share

Profitability

Net Income$240.82 million

Miscellaneous

Employees29,600
Market Cap$4.44 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.


MAXIMUS (NYSE:MMS) Frequently Asked Questions

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS announced a quarterly dividend on Wednesday, January 8th. Investors of record on Friday, February 14th will be given a dividend of $0.28 per share on Friday, February 28th. This represents a $1.12 annualized dividend and a yield of 1.61%. The ex-dividend date of this dividend is Thursday, February 13th. View MAXIMUS's Dividend History.

How will MAXIMUS's stock buyback program work?

MAXIMUS declared that its Board of Directors has initiated a share repurchase plan on Monday, June 25th 2018, which allows the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 4.9% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company's board believes its stock is undervalued.

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) announced its quarterly earnings results on Thursday, February, 6th. The health services provider reported $0.91 earnings per share for the quarter, meeting the consensus estimate of $0.91. The health services provider had revenue of $818.23 million for the quarter, compared to analysts' expectations of $797.11 million. MAXIMUS had a return on equity of 20.54% and a net margin of 8.01%. MAXIMUS's revenue was up 23.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.86 earnings per share. View MAXIMUS's Earnings History.

When is MAXIMUS's next earnings date?

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for MAXIMUS.

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS issued an update on its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of $3.95 to $4.15 for the period, compared to the Thomson Reuters consensus estimate of $4.02. The company issued revenue guidance of $3.15 billion to $3.30 billion, compared to the consensus revenue estimate of $3.22 billion.

What price target have analysts set for MMS?

2 Wall Street analysts have issued 12 month price objectives for MAXIMUS's stock. Their forecasts range from $77.00 to $81.00. On average, they expect MAXIMUS's share price to reach $79.00 in the next year. This suggests a possible upside of 13.7% from the stock's current price. View Analyst Price Targets for MAXIMUS.

What is the consensus analysts' recommendation for MAXIMUS?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Has MAXIMUS been receiving favorable news coverage?

Media headlines about MMS stock have been trending neutral recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. MAXIMUS earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned headlines about the health services provider a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for MAXIMUS.

Are investors shorting MAXIMUS?

MAXIMUS saw a increase in short interest in January. As of January 31st, there was short interest totalling 1,760,000 shares, an increase of 5.4% from the January 15th total of 1,670,000 shares. Based on an average trading volume of 379,700 shares, the short-interest ratio is presently 4.6 days. Approximately 2.8% of the shares of the company are sold short. View MAXIMUS's Current Options Chain.

Who are some of MAXIMUS's key competitors?

What other stocks do shareholders of MAXIMUS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Altria Group (MO), Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Wells Fargo & Co (WFC), Gilead Sciences (GILD), Intel (INTC), Qorvo (QRVO), AbbVie (ABBV) and Bristol-Myers Squibb (BMY).

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the folowing people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Former Pres of Tax & Employer Services (Age 57)

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (6.72%), Victory Capital Management Inc. (6.69%), State Street Corp (3.26%), FMR LLC (2.50%), Bank of New York Mellon Corp (1.66%) and Charles Schwab Investment Management Inc. (1.57%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Institutional Ownership Trends for MAXIMUS.

Which major investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Skandinaviska Enskilda Banken AB publ , Bamco Inc. NY, P2 Capital Partners LLC, FIL Ltd, AJO LP, DekaBank Deutsche Girozentrale, AXA and Standard Life Aberdeen plc. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Insider Buying and Selling for MAXIMUS.

Which major investors are buying MAXIMUS stock?

MMS stock was acquired by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., State of Michigan Retirement System, FMR LLC, Charles Schwab Investment Management Inc., UBS Group AG, Renaissance Technologies LLC, Alliancebernstein L.P. and Handelsbanken Fonder AB. View Insider Buying and Selling for MAXIMUS.

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $69.49.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.44 billion and generates $2.89 billion in revenue each year. The health services provider earns $240.82 million in net income (profit) each year or $3.72 on an earnings per share basis. MAXIMUS employs 29,600 workers across the globe.View Additional Information About MAXIMUS.

What is MAXIMUS's official website?

The official website for MAXIMUS is http://www.maximus.com/.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]


MarketBeat Community Rating for MAXIMUS (NYSE MMS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  419 (Vote Outperform)
Underperform Votes:  418 (Vote Underperform)
Total Votes:  837
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel